No doubt Pivalde will be pleased that Life Biosciences co founder David Sinclair is into mitochondria.Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.
David Andrew Sinclair, Ph.D.Nature reviews. Cardiology, January 1, 2019